Virus structure and structure-based antivirals

Structure-based antiviral developments in the past two years have been dominated by the structure determination and inhibition of SARS-CoV-2 proteins and new lead molecules for picornaviruses. The SARS-CoV-2 spike protein has been targeted successfully with antibodies, nanobodies, and receptor prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Plavec, Zlatka, Pöhner, Ina, Poso, Antti, Butcher, Sarah J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460353/
https://www.ncbi.nlm.nih.gov/pubmed/34564030
http://dx.doi.org/10.1016/j.coviro.2021.09.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460353/
https://www.ncbi.nlm.nih.gov/pubmed/34564030
http://dx.doi.org/10.1016/j.coviro.2021.09.005

Ejemplares similares